Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kelly Maloney

Concepts (360)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
2025
280
6.020
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
2024
75
1.570
 Why?
Antineoplastic Combined Chemotherapy Protocols
17
2025
1565
1.400
 Why?
Down Syndrome
6
2023
470
1.360
 Why?
Burkitt Lymphoma
3
2024
55
1.010
 Why?
Asparaginase
8
2020
29
0.900
 Why?
Leukemia, Myeloid, Acute
6
2024
591
0.810
 Why?
Child
71
2025
20721
0.780
 Why?
Consolidation Chemotherapy
2
2019
9
0.710
 Why?
Child, Preschool
47
2024
10373
0.640
 Why?
Disease-Free Survival
12
2024
656
0.600
 Why?
Leukemia
4
2021
229
0.580
 Why?
Oncogene Proteins, Fusion
6
2024
198
0.580
 Why?
Mercaptopurine
5
2017
15
0.550
 Why?
Neoplasm Recurrence, Local
5
2024
957
0.540
 Why?
Antineoplastic Agents
7
2019
2058
0.500
 Why?
Prognosis
15
2024
3780
0.490
 Why?
Preleukemia
1
2015
2
0.480
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
111
0.480
 Why?
Drug Hypersensitivity
3
2017
81
0.470
 Why?
Infant
34
2024
8913
0.470
 Why?
Molecular Targeted Therapy
3
2021
387
0.460
 Why?
Leukemia, Monocytic, Acute
1
2014
3
0.460
 Why?
Sarcoma, Myeloid
1
2014
4
0.450
 Why?
Recurrence
11
2024
1001
0.450
 Why?
Neoplasm, Residual
7
2023
118
0.430
 Why?
Adolescent
40
2024
20213
0.410
 Why?
Bone Marrow Transplantation
1
2014
268
0.410
 Why?
Medical Oncology
5
2025
272
0.400
 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
24
0.400
 Why?
Erwinia
2
2020
3
0.390
 Why?
Humans
83
2025
128524
0.380
 Why?
Tumor Suppressor Proteins
3
1999
312
0.380
 Why?
Acute Kidney Injury
1
2019
774
0.370
 Why?
Chromosome Aberrations
2
2022
147
0.370
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
573
0.370
 Why?
Neutropenia
2
2022
136
0.360
 Why?
Male
55
2024
62883
0.360
 Why?
Stem Cell Transplantation
3
2019
164
0.350
 Why?
Rhabdomyosarcoma
1
2011
64
0.340
 Why?
Cell Cycle Proteins
3
1999
580
0.340
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
113
0.340
 Why?
Carrier Proteins
3
1999
731
0.340
 Why?
Sarcoma, Ewing
1
2011
88
0.330
 Why?
Ploidies
2
2019
17
0.330
 Why?
Catheter-Related Infections
2
2022
68
0.310
 Why?
Survival Rate
8
2024
1872
0.310
 Why?
Core Binding Factor Alpha 2 Subunit
3
2021
32
0.310
 Why?
Genes, Tumor Suppressor
2
1999
86
0.310
 Why?
Cyclophosphamide
4
2019
231
0.300
 Why?
Female
53
2024
68127
0.300
 Why?
Catheterization, Central Venous
2
2022
97
0.300
 Why?
Philadelphia Chromosome
2
2018
18
0.280
 Why?
Medication Adherence
3
2017
573
0.260
 Why?
Gene Deletion
2
1998
372
0.260
 Why?
Vincristine
4
2021
110
0.260
 Why?
Trisomy
2
2021
77
0.250
 Why?
Antimetabolites, Antineoplastic
2
2017
90
0.250
 Why?
Neoplasm Proteins
2
2018
421
0.250
 Why?
Etoposide
2
2019
149
0.250
 Why?
Young Adult
15
2024
12320
0.240
 Why?
Treatment Outcome
12
2023
10163
0.230
 Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
69
0.230
 Why?
Anxiety
3
2016
949
0.220
 Why?
PAX5 Transcription Factor
2
2024
14
0.220
 Why?
Health Equity
1
2024
79
0.200
 Why?
Gene Rearrangement
3
2019
145
0.200
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
64
0.200
 Why?
Polyethylene Glycols
5
2020
597
0.200
 Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
3
0.200
 Why?
Induction Chemotherapy
2
2019
70
0.190
 Why?
Central Venous Catheters
1
2022
48
0.190
 Why?
Lymphoma
1
2023
194
0.190
 Why?
Doxorubicin
2
2022
322
0.190
 Why?
Adult
23
2023
35315
0.180
 Why?
Program Evaluation
2
2017
874
0.180
 Why?
Prednisone
2
2019
236
0.180
 Why?
Lung Neoplasms
1
2014
2323
0.180
 Why?
Translocation, Genetic
2
2013
97
0.180
 Why?
Polymorphism, Single Nucleotide
3
2017
2065
0.170
 Why?
Maintenance Chemotherapy
2
2017
22
0.170
 Why?
Bacterial Infections
1
2022
227
0.170
 Why?
Genomics
3
2024
716
0.170
 Why?
Risk Factors
11
2022
9727
0.170
 Why?
Immunocompromised Host
1
2021
195
0.170
 Why?
Diploidy
1
2019
13
0.160
 Why?
Quality of Life
3
2024
2680
0.160
 Why?
Genes, p16
1
1999
20
0.160
 Why?
Hyperglycemia
1
2023
325
0.160
 Why?
Prospective Studies
9
2022
7043
0.160
 Why?
Chromosomes, Human, Pair 19
1
1998
23
0.150
 Why?
Myelodysplastic Syndromes
1
2020
129
0.150
 Why?
Antibodies, Bispecific
1
2019
49
0.150
 Why?
Chromosomes, Human, Pair 17
1
1998
54
0.150
 Why?
Rituximab
1
2019
163
0.150
 Why?
Chromosomes, Human, Pair 1
1
1998
70
0.150
 Why?
Mutagenesis
1
1999
181
0.150
 Why?
Patient Safety
1
2021
290
0.150
 Why?
Prostate-Specific Antigen
2
2009
160
0.150
 Why?
Substance Withdrawal Syndrome
1
2020
171
0.140
 Why?
Proto-Oncogenes
1
1997
29
0.140
 Why?
Family Relations
2
2016
89
0.140
 Why?
Thioguanine
1
2017
18
0.140
 Why?
Thionucleotides
1
2017
34
0.140
 Why?
Oncologists
1
2017
36
0.140
 Why?
Apyrase
1
2017
17
0.140
 Why?
Follow-Up Studies
6
2021
4898
0.140
 Why?
Blast Crisis
1
2016
32
0.130
 Why?
Carboxypeptidases A
1
2016
2
0.130
 Why?
Retrospective Studies
10
2023
14460
0.130
 Why?
Depression
2
2016
1289
0.130
 Why?
Pediatricians
1
2017
132
0.130
 Why?
Sepsis
1
2022
556
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
283
0.130
 Why?
Mentors
2
2017
174
0.120
 Why?
Osteonecrosis
1
2015
24
0.120
 Why?
Adrenal Cortex Hormones
1
2019
518
0.120
 Why?
Nausea
1
2016
108
0.120
 Why?
Mentoring
1
2017
126
0.120
 Why?
Central Nervous System Neoplasms
1
2017
147
0.120
 Why?
Pancreatitis
1
2016
128
0.120
 Why?
Longitudinal Studies
7
2016
2697
0.120
 Why?
Dexamethasone
4
2021
336
0.120
 Why?
Mutation
4
2022
3692
0.120
 Why?
Monitoring, Physiologic
1
2017
267
0.120
 Why?
Fusion Proteins, bcr-abl
2
2016
63
0.120
 Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
16
0.110
 Why?
Cross Infection
1
2016
196
0.110
 Why?
Antigens, CD
1
2017
479
0.110
 Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
71
0.110
 Why?
Bacteremia
1
2016
188
0.110
 Why?
High-Throughput Nucleotide Sequencing
1
2017
485
0.110
 Why?
Flow Cytometry
1
2018
1141
0.110
 Why?
Repressor Proteins
1
1997
400
0.110
 Why?
Pediatrics
3
2021
1061
0.110
 Why?
Immunotherapy
1
2018
585
0.110
 Why?
DNA-Binding Proteins
2
1998
1415
0.110
 Why?
Life Change Events
1
2014
148
0.110
 Why?
Histone-Lysine N-Methyltransferase
2
2010
125
0.110
 Why?
Chromosomes, Human, Pair 21
1
2013
42
0.110
 Why?
Venous Thromboembolism
1
2017
274
0.100
 Why?
Quality Improvement
1
2021
1100
0.100
 Why?
Transcription Factors
2
1998
1631
0.100
 Why?
Leukemia, Megakaryoblastic, Acute
1
2012
10
0.100
 Why?
Self Report
1
2017
801
0.100
 Why?
Karyotyping
3
2019
107
0.100
 Why?
Myeloproliferative Disorders
1
2012
26
0.100
 Why?
Contraindications
1
2012
88
0.100
 Why?
Arabinonucleosides
1
2011
8
0.100
 Why?
Adenine Nucleotides
1
2011
22
0.100
 Why?
Cohort Studies
5
2021
5369
0.090
 Why?
Antibodies, Monoclonal
1
2018
1355
0.090
 Why?
Prostatic Neoplasms
2
2009
1010
0.090
 Why?
Chromosomes, Human, Pair 10
1
2010
18
0.090
 Why?
Chromosomes, Human, Pair 4
1
2010
28
0.090
 Why?
Pain
1
2016
756
0.080
 Why?
Multivariate Analysis
4
2015
1494
0.080
 Why?
T-Lymphocytes
1
2018
1922
0.080
 Why?
Parents
2
2016
1306
0.080
 Why?
Age Factors
8
2019
3117
0.080
 Why?
Prostatectomy
1
2009
105
0.080
 Why?
Bloom Syndrome
1
1988
1
0.080
 Why?
Neoplasm Metastasis
1
2011
608
0.080
 Why?
Gene Expression Regulation, Leukemic
2
2016
50
0.070
 Why?
Juxtaglomerular Apparatus
1
2007
1
0.070
 Why?
Risk Assessment
4
2024
3256
0.070
 Why?
Polymerase Chain Reaction
1
2010
1019
0.070
 Why?
Blood Coagulation
1
2008
226
0.070
 Why?
Drug Administration Schedule
2
2017
757
0.070
 Why?
Surveys and Questionnaires
4
2024
5346
0.060
 Why?
Clinical Trials as Topic
2
2024
998
0.060
 Why?
Stress, Psychological
1
2014
1058
0.060
 Why?
Methotrexate
2
2017
249
0.060
 Why?
Remission Induction
2
2019
269
0.060
 Why?
Drug Monitoring
2
2017
184
0.060
 Why?
Case-Control Studies
3
2024
3326
0.060
 Why?
Acute Disease
2
2019
968
0.060
 Why?
Selection Bias
1
2024
37
0.060
 Why?
Personal Satisfaction
2
2017
199
0.050
 Why?
Administration, Oral
2
2017
757
0.050
 Why?
Kidney Neoplasms
1
2007
349
0.050
 Why?
Genetic Variation
1
1988
934
0.050
 Why?
Risk
5
2023
852
0.050
 Why?
Randomized Controlled Trials as Topic
2
2020
1358
0.050
 Why?
Disease Progression
2
2021
2603
0.050
 Why?
Proto-Oncogene Proteins c-cbl
1
2022
11
0.050
 Why?
Incidence
2
2019
2619
0.050
 Why?
Transcriptome
2
2019
881
0.050
 Why?
Exome
1
2022
220
0.050
 Why?
Menorrhagia
1
2001
20
0.050
 Why?
Drug Therapy
1
2021
76
0.050
 Why?
Diarrhea
2
1999
177
0.040
 Why?
Bone Marrow
1
2022
267
0.040
 Why?
Endocrine Glands
1
1979
15
0.040
 Why?
Blood Cell Count
1
1999
54
0.040
 Why?
Chromosomes, Human
1
2019
41
0.040
 Why?
Viral Load
1
2021
450
0.040
 Why?
Azacitidine
1
2020
140
0.040
 Why?
Loss of Heterozygosity
1
1999
46
0.040
 Why?
Cytogenetic Analysis
1
2019
34
0.040
 Why?
Genome-Wide Association Study
2
2016
1337
0.040
 Why?
Mosaicism
1
2019
71
0.040
 Why?
Disinfectants
1
1999
35
0.040
 Why?
Sequence Deletion
1
1999
179
0.040
 Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
215
0.040
 Why?
Infant, Newborn
4
2019
5687
0.040
 Why?
National Cancer Institute (U.S.)
1
2018
43
0.040
 Why?
Chromosomes
1
2019
101
0.040
 Why?
Interviews as Topic
1
2021
705
0.040
 Why?
Hypertension
1
2007
1238
0.040
 Why?
Overweight
1
2023
525
0.040
 Why?
United States
4
2021
13876
0.040
 Why?
Escherichia coli O157
1
1998
30
0.040
 Why?
Methylation
1
1998
227
0.040
 Why?
Community Participation
1
1999
124
0.040
 Why?
Genetic Predisposition to Disease
2
2017
2266
0.040
 Why?
Erythrocyte Count
1
2017
21
0.040
 Why?
Glucose
1
2023
983
0.040
 Why?
Biopsy
1
2021
1085
0.040
 Why?
Escherichia coli Infections
1
1998
106
0.040
 Why?
Public Health Surveillance
1
2017
67
0.040
 Why?
Injections, Intramuscular
1
2017
117
0.040
 Why?
Food-Drug Interactions
1
2017
8
0.040
 Why?
Leucovorin
1
2017
68
0.030
 Why?
Proto-Oncogene Proteins c-ets
1
1997
53
0.030
 Why?
Career Mobility
1
2017
68
0.030
 Why?
Family
1
2021
642
0.030
 Why?
Feasibility Studies
1
2021
860
0.030
 Why?
Cranial Irradiation
1
2017
68
0.030
 Why?
Water Purification
1
1999
146
0.030
 Why?
Hemorrhage
1
2001
644
0.030
 Why?
Dairy Products
1
2017
36
0.030
 Why?
Cerebrospinal Fluid
1
2017
89
0.030
 Why?
MEF2 Transcription Factors
1
2016
62
0.030
 Why?
Infusions, Intravenous
1
2017
384
0.030
 Why?
Sulfonamides
1
2020
500
0.030
 Why?
NIH 3T3 Cells
1
2016
141
0.030
 Why?
Luciferases
1
2016
147
0.030
 Why?
Leukocyte Count
1
2017
327
0.030
 Why?
Methyltransferases
1
2017
69
0.030
 Why?
Methyl Ethers
1
1996
8
0.030
 Why?
Ethers
1
1996
16
0.030
 Why?
Anesthetics, Inhalation
1
1996
17
0.030
 Why?
Bone Morphogenetic Protein 7
1
2015
9
0.030
 Why?
Fluorides
1
1996
49
0.030
 Why?
Breast Neoplasms
5
1979
2139
0.030
 Why?
Middle Aged
10
2019
30893
0.030
 Why?
Cytarabine
1
2016
55
0.030
 Why?
Health Education
1
1999
331
0.030
 Why?
Genotype
3
2017
1831
0.030
 Why?
Severity of Illness Index
2
2017
2736
0.030
 Why?
Disease Management
1
2019
588
0.030
 Why?
Alternative Splicing
1
2017
218
0.030
 Why?
Histone Deacetylase Inhibitors
1
2016
206
0.030
 Why?
Intensive Care Units, Pediatric
1
2016
191
0.030
 Why?
Qualitative Research
1
2021
1205
0.030
 Why?
Homeodomain Proteins
1
1998
487
0.030
 Why?
Promoter Regions, Genetic
1
1999
1199
0.030
 Why?
HEK293 Cells
1
2017
681
0.030
 Why?
Sequence Analysis, RNA
1
2016
428
0.030
 Why?
Biomarkers, Tumor
1
2021
1182
0.030
 Why?
DNA Methylation
1
1999
604
0.030
 Why?
Aged
9
2019
21971
0.030
 Why?
Algorithms
1
2021
1616
0.030
 Why?
Psychomotor Agitation
1
2014
65
0.030
 Why?
Behavior
1
2014
91
0.030
 Why?
Marriage
1
2014
113
0.030
 Why?
Demography
1
2014
277
0.030
 Why?
Income
1
2014
189
0.030
 Why?
Blood Glucose
1
2023
2092
0.030
 Why?
Base Sequence
1
2016
2134
0.030
 Why?
Odds Ratio
1
2015
1022
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2013
313
0.020
 Why?
Aggression
1
2014
196
0.020
 Why?
Nucleoside Transport Proteins
1
2011
4
0.020
 Why?
Time Factors
2
2015
6503
0.020
 Why?
Regression Analysis
1
2014
983
0.020
 Why?
Erythrocytes
1
2017
670
0.020
 Why?
Antineoplastic Agents, Alkylating
1
2011
69
0.020
 Why?
Escherichia coli
1
2015
770
0.020
 Why?
Mice
2
2019
16579
0.020
 Why?
Antineoplastic Agents, Phytogenic
1
2011
186
0.020
 Why?
Survival Analysis
1
2013
1265
0.020
 Why?
Logistic Models
1
2015
1975
0.020
 Why?
Bacteria
1
2016
811
0.020
 Why?
Obesity
1
2023
2860
0.020
 Why?
Prevalence
1
2016
2549
0.020
 Why?
Kaplan-Meier Estimate
1
2011
857
0.020
 Why?
Emotions
1
2014
533
0.020
 Why?
Sister Chromatid Exchange
1
1988
4
0.020
 Why?
Genetic Complementation Test
1
1988
63
0.020
 Why?
Cell Fusion
1
1988
51
0.020
 Why?
Mice, Inbred C57BL
1
2019
5257
0.020
 Why?
Protein C
1
2008
39
0.020
 Why?
Water Microbiology
2
1999
85
0.020
 Why?
Plasminogen Activator Inhibitor 1
1
2008
83
0.020
 Why?
Antithrombins
1
2008
53
0.020
 Why?
Fibrinogen
1
2008
158
0.020
 Why?
Genetic Markers
1
1988
339
0.020
 Why?
Transplantation, Homologous
1
2008
396
0.020
 Why?
Biopsy, Needle
1
2007
189
0.020
 Why?
Renin-Angiotensin System
1
2007
80
0.020
 Why?
Rare Diseases
1
2007
103
0.020
 Why?
Blood Pressure Determination
1
2007
150
0.020
 Why?
Biomarkers
1
2017
3881
0.020
 Why?
Nephrectomy
1
2007
159
0.020
 Why?
Animals
2
2019
34501
0.020
 Why?
RNA, Messenger
1
2011
2674
0.010
 Why?
Immunohistochemistry
1
2007
1669
0.010
 Why?
Cell Line
1
1988
2731
0.010
 Why?
Anemia, Hypochromic
1
2001
4
0.010
 Why?
Blood Platelet Disorders
1
2001
10
0.010
 Why?
von Willebrand Diseases
1
2001
17
0.010
 Why?
Estriol
1
1979
7
0.010
 Why?
Estrone
1
1979
37
0.010
 Why?
Menstruation
1
1979
44
0.010
 Why?
Prolactin
1
1979
97
0.010
 Why?
Thrombocytopenia
1
2001
182
0.010
 Why?
Bolivia
1
1999
63
0.010
 Why?
Luteinizing Hormone
1
1979
178
0.010
 Why?
Follicle Stimulating Hormone
1
1979
239
0.010
 Why?
Restaurants
1
1998
19
0.010
 Why?
Swimming
1
1998
47
0.010
 Why?
Food Handling
1
1998
60
0.010
 Why?
Progesterone
1
1979
244
0.010
 Why?
Disease Transmission, Infectious
1
1998
57
0.010
 Why?
Water Supply
1
1998
74
0.010
 Why?
Meat
1
1998
93
0.010
 Why?
Halothane
1
1996
6
0.010
 Why?
Estradiol
1
1979
497
0.010
 Why?
Analysis of Variance
1
1999
1271
0.010
 Why?
Population Surveillance
1
1999
427
0.010
 Why?
Feces
1
1998
432
0.010
 Why?
Ovarian Neoplasms
1
1978
489
0.010
 Why?
Pedigree
3
1978
485
0.010
 Why?
Kidney
1
1996
1305
0.000
 Why?
Aged, 80 and over
1
1999
7040
0.000
 Why?
Nebraska
2
1976
9
0.000
 Why?
New York
2
1976
123
0.000
 Why?
Genes
1
1978
226
0.000
 Why?
Genetic Linkage
1
1978
299
0.000
 Why?
Oncogenic Viruses
1
1976
3
0.000
 Why?
Apocrine Glands
1
1976
4
0.000
 Why?
Genetic Techniques
1
1976
64
0.000
 Why?
Pheochromocytoma
1
1976
57
0.000
 Why?
Klinefelter Syndrome
1
1976
56
0.000
 Why?
Syndrome
1
1976
335
0.000
 Why?
Statistics as Topic
1
1976
304
0.000
 Why?
Pregnancy
2
1978
6297
0.000
 Why?
HLA Antigens
1
1976
235
0.000
 Why?
Abnormalities, Multiple
1
1976
178
0.000
 Why?
Skin Diseases
1
1976
142
0.000
 Why?
Sarcoma
1
1976
177
0.000
 Why?
Sex Factors
1
1978
1949
0.000
 Why?
Thyroid Neoplasms
1
1976
311
0.000
 Why?
Neoplasms
2
1976
2465
0.000
 Why?
Melanoma
1
1976
749
0.000
 Why?
Registries
1
1976
1878
0.000
 Why?
Phenotype
1
1976
3050
0.000
 Why?
Brain Neoplasms
1
1976
1149
0.000
 Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (360) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)